CN105535861B - 一种治疗前列腺炎的中药制剂及其制作方法 - Google Patents
一种治疗前列腺炎的中药制剂及其制作方法 Download PDFInfo
- Publication number
- CN105535861B CN105535861B CN201610052865.1A CN201610052865A CN105535861B CN 105535861 B CN105535861 B CN 105535861B CN 201610052865 A CN201610052865 A CN 201610052865A CN 105535861 B CN105535861 B CN 105535861B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine preparation
- raw material
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 238000002360 preparation method Methods 0.000 title claims abstract description 54
- 201000007094 prostatitis Diseases 0.000 title abstract description 30
- 235000007354 Coix lacryma jobi Nutrition 0.000 claims abstract description 15
- 241000218231 Moraceae Species 0.000 claims abstract description 15
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 15
- 244000292697 Polygonum aviculare Species 0.000 claims abstract description 14
- 235000006386 Polygonum aviculare Nutrition 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 43
- 239000002994 raw material Substances 0.000 claims description 40
- 239000000843 powder Substances 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 238000000605 extraction Methods 0.000 claims description 16
- 241001233914 Chelidonium majus Species 0.000 claims description 14
- 244000163122 Curcuma domestica Species 0.000 claims description 14
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 14
- 241000218916 Cycas Species 0.000 claims description 14
- 241000345784 Neolepisorus Species 0.000 claims description 14
- 125000003118 aryl group Chemical group 0.000 claims description 14
- 235000003373 curcuma longa Nutrition 0.000 claims description 14
- 229940068560 greater celandine Drugs 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 14
- 235000013976 turmeric Nutrition 0.000 claims description 14
- 241000737263 Lygodium Species 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 235000010894 Artemisia argyi Nutrition 0.000 claims description 10
- 244000030166 artemisia Species 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 230000006837 decompression Effects 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 238000004064 recycling Methods 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 241000345998 Calamus manan Species 0.000 claims description 3
- 235000012950 rattan cane Nutrition 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims 1
- 240000002853 Nelumbo nucifera Species 0.000 claims 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims 1
- 238000007598 dipping method Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 24
- 210000003734 kidney Anatomy 0.000 abstract description 18
- 210000000952 spleen Anatomy 0.000 abstract description 13
- 208000004880 Polyuria Diseases 0.000 abstract description 10
- 230000035619 diuresis Effects 0.000 abstract description 10
- 230000004087 circulation Effects 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 244000241235 Citrullus lanatus Species 0.000 abstract description 2
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 abstract description 2
- 230000001939 inductive effect Effects 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 241001407408 Berberis fortunei Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 241001306121 Dracaena <Squamata> Species 0.000 abstract 1
- 241000345811 Neocheiropteris ovata Species 0.000 abstract 1
- 240000007284 Stenochlaena palustris Species 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 23
- 239000008280 blood Substances 0.000 description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 201000010099 disease Diseases 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 206010003549 asthenia Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000003393 splenic effect Effects 0.000 description 7
- 210000002700 urine Anatomy 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 210000002307 prostate Anatomy 0.000 description 6
- 229920001353 Dextrin Polymers 0.000 description 5
- 239000004375 Dextrin Substances 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 208000031975 Yang Deficiency Diseases 0.000 description 5
- 208000031971 Yin Deficiency Diseases 0.000 description 5
- 235000019425 dextrin Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 210000002640 perineum Anatomy 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 238000005550 wet granulation Methods 0.000 description 5
- 235000020985 whole grains Nutrition 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010033799 Paralysis Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 208000006750 hematuria Diseases 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010018612 Gonorrhoea Diseases 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000004908 prostatic fluid Anatomy 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 210000003708 urethra Anatomy 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 206010042170 Strangury Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000146 antalgic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000013507 chronic prostatitis Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 229960005489 paracetamol Drugs 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000031973 Conjunctivitis infective Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 101100276976 Drosophila melanogaster Drak gene Proteins 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010016029 Face oedema Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000000450 Pelvic Pain Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010052531 Testis discomfort Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 201000001028 acute contagious conjunctivitis Diseases 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- NNBFNNNWANBMTI-UHFFFAOYSA-M brilliant green Chemical compound OS([O-])(=O)=O.C1=CC(N(CC)CC)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](CC)CC)C=C1 NNBFNNNWANBMTI-UHFFFAOYSA-M 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004995 male reproductive system Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 230000003202 urodynamic effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗前列腺炎的中药制剂及其制备方法,属于医药技术领域。该中药制剂包括如下重量份的原料:大金刀15‑20份、牛抄藤10‑15份、西瓜翠衣10‑15份、铁树叶15‑20份、半枝莲15‑20份、首乌藤10‑20份、泽兰6‑12份、黄精10‑15份、功劳子5‑9份、薏苡根9‑15份、桑葚10‑15份、五加皮6‑15份、艾实2‑5份、郁金3‑10份、白屈菜3‑6份。该中药制剂具有清热解毒、利湿利尿、祛瘀散结、补肾健脾、行气解郁之功效,可从根本上治愈前列腺炎,对不同证型的前列腺炎均有很好的疗效,治愈率高,且安全可靠,无毒副作用。
Description
【技术领域】
本发明涉及医药技术领域,尤其是一种治疗前列腺炎的中药制剂及其制备方法。
【技术背景】
前列腺炎是泌尿男性生殖系统的常见病,占泌尿生殖系统患病率的25%以上,在50岁以下的男性中最为常见。它是由多种复杂原因和诱因引起的前列腺的炎症、免疫、神经内分泌参与的错综的病理变化,导致以尿道刺激症状和慢性盆腔疼痛为主要临床表现的疾病,可分为急性前列腺炎和慢性前列腺炎。其中,急性前列腺炎是由细菌感染而起的急性前列腺炎证;慢性前列腺炎常由急性前列腺炎转变而来,也可能由病毒感染、泌尿结石、前列腺慢性充血等引起。其临床表现为:会阴、耻骨上区、腹股沟区、生殖器疼痛不适;排尿时尿道不适或有烧灼感、尿急、尿频、排尿疼痛,或伴有排尿终末血尿或尿道脓性分泌物;急性感染还可能伴有恶寒、发热、乏力等全身症状。前列腺炎虽不是一种直接威胁生命的疾病,但严重影响患者的生活质量。目前,治疗前列腺炎的方法很多,有口服西药、中药、局部注射、手术等,但疗效都不明显,治疗周期长,疗效不佳,易复发,有些抗生素类药物还存在一定的副作用,不宜长期服用,而手术疗法的创伤大,患者较为痛苦。我国用传统中医治疗前列腺炎的配方有多种,虽然这些配方在治疗前列腺炎方面各有特点,但都存在其局限性,疗效不一,不能让人满意。
【发明内容】
针对以上提出的问题,本发明提供了一种治疗前列腺炎的中药制剂及其制备方法,该中药制剂是一种辩证治疗的药物,具有针对性高、疗程短、疗效好、无毒副作用和治愈后不易复发的优点。
在中医中,前列腺炎属精浊、淋浊等范畴,主要病机是为虚实夹杂症,邪实在不同类型可有不同,或因热毒炽热、湿热互结、淤血内停;本虚主要为肾虚,另有脾虚、肝虚,根据所述治病机理,可将前列腺炎分为湿热下注型、脾虚湿盛型、气滞血痪型、肝肾阴虚型和肾阳不足型。本发明中药制剂根据上述病症机理进行研制,具体采用的技术方案为:
一种治疗前列腺炎的中药制剂,所述中药制剂包括如下重量份的原料:大金刀15-20份、牛抄藤10-15份、西瓜翠衣10-15份、铁树叶15-20份、半枝莲15-20份、首乌藤10-20份、泽兰6-12份、黄精10-15份、功劳子5-9份、薏苡根9-15份、桑葚10-15份、五加皮6-15份、艾实2-5份、郁金3-10份、白屈菜3-6份。
进一步地,所述中药制剂包括如下重量份的原料:大金刀17-19份、牛抄藤12-14份、西瓜翠衣12-14份、铁树叶17-19份、半枝莲17-19份、首乌藤13-17份、泽兰8-10份、黄精12-14份、功劳子6-8份、薏苡根11-14份、桑葚12-14份、五加皮9-13份、艾实3-4份、郁金5-8份、白屈菜4-5份。
进一步地,所述中药制剂包括如下重量份的原料:大金刀18份、牛抄藤13份、西瓜翠衣13份、铁树叶18份、半枝莲18份、首乌藤15份、泽兰9份、黄精13份、功劳子7份、薏苡根12份、桑葚13份、五加皮11份、艾实4份、郁金7份、白屈菜5份。
进一步地,所述中药制剂为颗粒剂、片剂或胶囊剂。
本发明还提供上述中药制剂的制备方法,包括以下步骤:
1)按照上述重量份称取所述原料;
2)将步骤1)所取的原料洗净晾干后,切断至长度小于1cm;而后加入原料总质量8-10倍且体积浓度为60-80%的乙醇水溶液浸泡1-3h,随后回流提取2-3次,每次1-2h,合并每次提取所得滤液,减压回收乙醇,再进行浓缩、干燥、粉碎,得醇提取物干粉;醇提取所剩余的药渣保留,备用;
3)向步骤2)醇提取所剩余的药渣中加入原料总重量6-8倍的水,加热回流提取2次,每次2-3小时,合并两次提取液,进而进行浓缩、干燥、粉碎,得水提取物干粉;
4)将步骤2)所得醇提取物干粉和步骤3)所得水提取物干粉混合均匀,加入药学上可以接收的辅料,制成颗粒剂、片剂或胶囊剂。
本发明所采用的中药详细情况如下:
大金刀:味苦,性凉。归心、肺、膀胱经。具有清热利湿、散瘀止血、解毒的功效。可用于热淋、尿路感染、小便不利、尿血、肺痨咯血、吐血、外伤出血、痈肿、水火烫伤。
牛抄藤:味甘、微苦,性寒。归肾、肝、大肠经。具有舒筋活络、清热利湿、利尿、消炎消肿、止血的功效。主风湿麻木,跌打损伤,尿路感染,泌尿系结石,肾炎水肿,痢疾,疮痈肿毒,小儿口疮,火眼,癣疾,外伤出血。
西瓜翠衣:味甘、淡,性凉。归心、胃、膀胱经。具有清热解暑、泻热除烦、利尿的功效。用于暑热烦渴、小便短赤、咽喉肿痛,或口舌生疮,浮肿等症。
铁树叶:味甘淡,性凉。具有清热、止血、散瘀的功效。治痢疾,吐血,便血,胃痛,尿血,月经过多,跌打肿痛。
半枝莲:味辛、苦,性寒。归肺、肝、肾经。具有清热、解毒、散瘀、止血、定痛的功效。治尿道炎,小便尿血疼痛,吐血,衄血,血淋,赤痢,黄疸,咽喉疼痛,肺痈,疔疮,瘰疬,疮毒,癌肿,跌打刀伤,蛇咬伤。
首乌藤:味甘、微苦,性平。归心、肝经。具有养心、安神、通络、祛风的功效。治失眠,劳伤,多汗,血虚身痛,痈疽,瘰疬,风疮疥癣。
泽兰:味苦、辛,性微温。归肝、脾经。具有活血痛经、利水消肿的功效。治经闭,癥瘕,产后瘀滞腹痛,身面浮肿,跌扑损伤,金疮,痈肿。
黄精:味甘,性平。归脾、肺、肾经。具有养阴润肺、补脾益气、滋肾填精的功效。主阴虚劳嗽,肺燥咳嗽,脾虚乏力,食少口干,消渴,肾亏腰膝酸软,阳痿遗精,耳鸣目暗,须发早白,体虚赢瘦,风癞癣疾。
功劳子:味苦、涩,性微温。归肝、肾经。具有清虚热、补肾、燥湿的功效。主骨蒸潮热,腰膝酸软,头晕耳鸣,湿热腹泻,带下,淋浊。
薏苡根:味甘、淡,性微寒。归脾、膀胱经。具有清热、利湿通淋、健脾、杀虫的功效。治黄疸,水肿,淋病,疝气,经闭,带下,虫积腹痛。
桑葚:味甘、酸,性寒。归心、肝、肾经。具有滋阴养血、生津、润肠的功效。主肝肾不足和血虚精亏的头晕目眩,腰酸耳鸣,须发早白,失眠多梦,津伤口渴,消渴,肠燥便秘。
五加皮:味辛、微苦,性温。归脾、肾、心经。具有益气健脾、补肾安神的功效。用于脾肾阳虚,体虚乏力,食欲不振,腰膝酸痛,失眠多梦。
艾实:味苦、辛,性温。具有温肾壮阳的功效。主肾虚腰酸,阳虚内寒,明目,壮阳,助水藏,利腰、膝及暖子宫。
郁金:味辛、苦,性寒。归心、肝、胆经。具有行气解郁、活血止痛、利胆退黄的功效。治胸腹胁肋诸痛,失心癫狂,热病神昏,吐血,衄血,尿血,血淋,妇女倒经,黄疸。
白屈菜:味苦辛,性微温。归肺、心、肾经。具有镇痛镇静、消炎杀菌、利尿、止咳、清热解毒的功效。用于胃痛,腹痛,肠炎,痢疾,慢性支气管炎,百日咳,咳嗽,黄疸,水肿,腹水,疥癣疮肿,蛇虫咬伤。
本发明提供了一种治疗前列腺炎的中药制剂及其制备方法,与现有技术相比,具有以下有益效果:
本发明所提供的治疗前列腺炎的中药制剂根据前列腺炎的治病机理进行配药,以大金刀、牛抄藤、西瓜翠衣、铁树叶、半枝莲、首乌藤、泽兰、黄精、功劳子、薏苡根、桑葚、五加皮、艾实、郁金、白屈菜为主要原料,其中,以清热利湿、利尿、解毒的大金刀、牛抄藤、西瓜翠衣为君药;以活血、散瘀、通络、定痛的铁树叶、半枝莲、何首乌、泽兰为臣药;佐以补肾壮阳、健脾滋肝的黄精、功劳子、薏苡根、桑葚、五加皮、艾实,行气解郁、活血止痛的郁金,以及杀菌消炎、镇痛镇静、清热解毒的白屈菜。以上诸药配伍,相得益彰,共奏清热解毒、利湿利尿、祛瘀散结、补肾健脾、行气解郁之功效,对于不同病因引起的前列腺炎均有很好的疗效,疗程短,治愈率高,治愈后不易复发,且药性温和,安全可靠,无任何毒副作用。
【具体实施方式】
下面的实施例可以帮助本领域的技术人员更全面的理解本发明,但不可以以任何方式限制本发明。
实施例1
一种治疗前列腺炎的中药颗粒制剂,其包括如下重量份的原料:大金刀15份、牛抄藤10份、西瓜翠衣10份、铁树叶15份、半枝莲15份、首乌藤10份、泽兰6份、黄精10份、功劳子5份、薏苡根9份、桑葚10份、五加皮6份、艾实2份、郁金3份、白屈菜3份。具体制备方法包括以下步骤:
1)按照上述重量份称取所述原料;
2)将步骤1)所取的原料洗净晾干后,切断至长度小于1cm,而后加入原料总质量8倍且体积浓度为80%的乙醇水溶液浸泡1h,随后回流提取3次,每次1h,合并每次提取所得滤液,减压回收乙醇,再进行浓缩、干燥、粉碎,得醇提取物干粉;醇提取所剩余的药渣保留,备用;
3)向步骤2)醇提取所剩余的药渣中加入原料总重量6倍的水,加热回流提取2次,每次2小时,合并两次提取液,进而进行浓缩、干燥、粉碎,得水提取物干粉;
4)将步骤2)所得醇提取物干粉和步骤3)所得水提取物干粉混合均匀,加入适量辅料微粉硅胶、糊精和淀粉并混匀,而后采用湿法制粒、干燥,经整粒后装袋,制成颗粒制剂,包装成袋,每袋6g。
实施例2
一种治疗前列腺炎的中药片剂,其包括如下重量份的原料:大金刀17份、牛抄藤12份、西瓜翠衣12份、铁树叶17份、半枝莲17份、首乌藤13份、泽兰8份、黄精12份、功劳子6份、薏苡根11份、桑葚12份、五加皮9份、艾实3份、郁金5份、白屈菜4份。具体制备方法包括以下步骤:
1)按照上述重量份称取所述原料;
2)将步骤1)所取的原料洗净晾干后,切断至长度小于1cm,而后加入原料总质量9倍且体积浓度为65%的乙醇水溶液浸泡2.5h,随后回流提取3次,每次1.5h,合并每次提取所得滤液,减压回收乙醇,再进行浓缩、干燥、粉碎,得醇提取物干粉;醇提取所剩余的药渣保留,备用;
3)向步骤2)醇提取所剩余的药渣中加入原料总重量6倍的水,加热回流提取2次,每次3小时,合并两次提取液,进而进行浓缩、干燥、粉碎,得水提取物干粉;
4)将步骤2)所得醇提取物干粉和步骤3)所得水提取物干粉混合均匀,加入适量辅料微粉硅胶、糊精和淀粉并混匀,而后采用湿法制粒、干燥,经整粒后压片制成片剂,每片0.3g。
实施例3
一种治疗前列腺炎的中药胶囊剂,其包括如下重量份的原料:大金刀18份、牛抄藤13份、西瓜翠衣13份、铁树叶18份、半枝莲18份、首乌藤15份、泽兰9份、黄精13份、功劳子7份、薏苡根12份、桑葚13份、五加皮11份、艾实4份、郁金7份、白屈菜5份。具体制备方法包括以下步骤:
1)按照上述重量份称取所述原料;
2)将步骤1)所取的原料洗净晾干后,切断至长度小于1cm,而后加入原料总质量9倍且体积浓度为70%的乙醇水溶液浸泡2h,随后回流提取2次,每次2h,合并每次提取所得滤液,减压回收乙醇,再进行浓缩、干燥、粉碎,得醇提取物干粉;醇提取所剩余的药渣保留,备用;
3)向步骤2)醇提取所剩余的药渣中加入原料总重量7倍的水,加热回流提取2次,每次2.5小时,合并两次提取液,进而进行浓缩、干燥、粉碎,得水提取物干粉;
4)将步骤2)所得醇提取物干粉和步骤3)所得水提取物干粉混合均匀,加入适量辅料糊精和淀粉并混匀,而后采用湿法制粒、干燥,经整粒后灌装制成胶囊剂,每粒0.5g。
实施例4
一种治疗前列腺炎的中药胶囊剂,其包括如下重量份的原料:大金刀19份、牛抄藤14份、西瓜翠衣14份、铁树叶19份、半枝莲19份、首乌藤17份、泽兰10份、黄精14份、功劳子8份、薏苡根14份、桑葚14份、五加皮13份、艾实4份、郁金8份、白屈菜5份。具体制备方法包括以下步骤:
1)按照上述重量份称取所述原料;
2)将步骤1)所取的原料洗净晾干后,切断至长度小于1cm,而后加入原料总质量10倍且体积浓度为60%的乙醇水溶液浸泡3h,随后回流提取3次,每次1h,合并每次提取所得滤液,减压回收乙醇,再进行浓缩、干燥、粉碎,得醇提取物干粉;醇提取所剩余的药渣保留,备用;
3)向步骤2)醇提取所剩余的药渣中加入原料总重量8倍的水,加热回流提取2次,每次3小时,合并两次提取液,进而进行浓缩、干燥、粉碎,得水提取物干粉;
4)将步骤2)所得醇提取物干粉和步骤3)所得水提取物干粉混合均匀,加入适量辅料糊精和淀粉并混匀,而后采用湿法制粒、干燥,经整粒后灌装制成胶囊剂,每粒0.5g。
实施例5
一种治疗前列腺炎的中药颗粒制剂,其包括如下重量份的原料:大金刀20份、牛抄藤15份、西瓜翠衣15份、铁树叶20份、半枝莲20份、首乌藤20份、泽兰12份、黄精15份、功劳子9份、薏苡根15份、桑葚15份、五加皮15份、艾实5份、郁金10份、白屈菜6份。具体制备方法包括以下步骤:
1)按照上述重量份称取所述原料;
2)将步骤1)所取的原料洗净晾干后,切断至长度小于1cm,而后加入原料总质量10倍且体积浓度为75%的乙醇水溶液浸泡1.5h,随后回流提取2次,每次2h,合并每次提取所得滤液,减压回收乙醇,再进行浓缩、干燥、粉碎,得醇提取物干粉;醇提取所剩余的药渣保留,备用;
3)向步骤2)醇提取所剩余的药渣中加入原料总重量7倍的水,加热回流提取2次,每次2小时,合并两次提取液,进而进行浓缩、干燥、粉碎,得水提取物干粉;
4)将步骤2)所得醇提取物干粉和步骤3)所得水提取物干粉混合均匀,加入适量辅料微粉硅胶、糊精和淀粉并混匀,而后采用湿法制粒、干燥,经整粒后包装,制成颗粒制剂,包装成袋,每袋6g。
本发明治疗前列腺炎的临床观察统计资料
1、观察对象:
观察2014年1月-2015年3月期间年龄在21-50岁之间的门诊病历135例,并随机分为两组,治疗组100例和对照组35例,其中,治疗组的年龄在21-50岁之间,病程最短1年,最长8年;对照组的年龄在22-48岁之间,病程最短半年,最长7年。治疗组100中,中医辨证属湿热下注型23例,脾虚湿盛型24例,气滞血痪型21例,肝肾阴虚型17例,肾阳不足型15。而对照组随机分为两组,对照组A 17例和对照组B 18例。
2、诊断标准
所有观察对象都呈现不同程度的前列腺炎症状,临床表现如下:尿急、尿频、尿灼痛、尿淋漓、夜尿增多,会阴部、骶部、下腹部、腹股沟、尿道或睾丸不适或胀痛、排尿终末血尿或尿道脓性分泌物,性功能异常(阳痿、遗精、早泄、性欲减退等),并可能伴有焦虑、抑郁、失眠、记忆力下降。直肠指检:前列腺体积不正常,表面不平,硬度不均匀,局部压痛。前列腺液检测:白细胞>10个/HP,卵磷脂小体减少。
3、治疗方法
治疗组:内服本发明中药制剂,每日3次,每次服用有效药量为1-2g的中药制剂,饭后半小时温水服用,15天为一个疗程,疗程间隔3-5天,服用2-6个疗程后进行观察,服药期间停服其他药物,并忌食生冷、辛辣、刺激的食物。
对照组:对照组A口服前列腺舒丸,每日3次,一次1-2丸;对照组B口服普乐安片,每日3次,一次3-4片。饭后半小时温水服用,15天为一个疗程,疗程间隔3-5天,服用2-6个疗程后进行观察,服药期间停服其他药物,并忌食生冷、辛辣、刺激的食物。
4、治疗标准
治愈:症状消失,前列腺液检查正常;
有效:症状明显改善,前列腺液检查明显好转;
无效:症状及前列腺液检查无改善。
5、治疗结果
治疗组和对照组临床治疗结果如表1所示,治疗组不同症型的治疗结果如表2所示,2个对照组的治疗结果如表3所示。
表1治疗组和对照组临床治疗结果
n | 痊愈 | 有效 | 无效 | 总有效率(%) | |
治疗组 | 100 | 56 | 37 | 7 | 93 |
对照组 | 35 | 3 | 21 | 11 | 68.6 |
表2治疗组不同症型的治疗结果
n | 痊愈 | 有效 | 无效 | 总有效率(%) | |
湿热下注型 | 23 | 13 | 10 | 0 | 100 |
脾虚湿盛型 | 24 | 15 | 8 | 1 | 95.8 |
气滞血痪型 | 21 | 9 | 9 | 3 | 85.7 |
肝肾阴虚型 | 17 | 10 | 5 | 2 | 88.2 |
肾阳不足型 | 15 | 9 | 5 | 1 | 93.3 |
表3 2个对照组的治疗结果
n | 痊愈 | 有效 | 无效 | 总有效率(%) | |
对照组A | 17 | 1 | 10 | 6 | 64.7 |
对照组B | 18 | 2 | 11 | 5 | 72.2 |
由上表1治疗组和对照组的临床治疗结果可以看出:治疗组100例,服用本发明治疗前列腺炎的中药制剂2-4个疗程后,治愈56例(占总数56%),有效37例(占总数37%),无效7例(占总数7%),总有效率为93%;对照组35例,服用目前市售的前列腺炎药物2-4个疗程之后,治愈3例(占总数8.6%),有效21例(占总数60%),无效11例(占总数31.4%),总有效率为68.6%;可见,本发明中药制剂用于治疗前列腺炎效果好,治愈率高。由表2治疗组不同症型的治疗结果可以看出:采用本发明中药制剂对治疗组中不同症型的病例组进行治疗,经过2-4个疗程后,湿热下注型、脾虚湿盛型、气滞血痪型、肝肾阴虚型、肾阳不足型,各证型前列腺炎病例组的总有效率分别为100%、95.8%、85.7%、88.2%、93.3%,由此可见,本发明中药制剂对不同病因引起的前列腺炎症均能起到较好的治疗效果,其中对于湿热下注型、脾虚湿盛型前列腺炎的疗效尤为显著。由表3中数据,对照组A和对照组B分别采用市售的前列腺舒丸和普乐安片治疗前列腺炎,两者的总有效率分别为64.7%、72.2%,结合表1和表2可以看出,本发明中药制剂治疗前列腺炎的效果比市售的前列腺炎药物更好,治愈率更高。
综上所述,相对于市售现有的前列腺炎药物,本发明中药制剂治疗前列腺炎的效果更佳,治愈率更高;且本发明中药制剂对于不同病因引起的前列腺炎均能起到较好的疗效,其中,针对湿热下注型、脾虚湿盛型前列腺炎的疗效尤为显著。
典型病例
病例1:赵某某,男,25岁,患前列腺炎1年有余,主要症状:小便淋涩赤痛,会阴部及小腹下坠胀痛,尿道口滴白浊,舌苔黄腻,脉滑数,确诊为湿热下注性前列腺炎。先后用过多种药物,治疗效果均不明显,对其造成较大困扰,易焦虑。之后经推荐服用本发明中药制剂,使用1个疗程之后,病症明显减轻,3个疗程之后,以上症状完全消失,一年后回访未见复发。
病例2:韩某某,37岁,患前列腺炎2年有余,主要症状:小便流浊,会阴坠胀,面色不华,肢体困倦,不思饮食,舌淡苔白,脉虚,确诊为脾虚湿盛型前列腺炎,经多方治疗效果不佳,之后服用本发明中药制剂,治疗2个疗程之后,上述病症明显减轻,继续服用3个疗程,所有症状消失,至今已有2年,未见复发。
病例3:霍某某,42岁,患前列腺炎将近5年,主要症:症见尿道口常有白浊、会阴坠胀,腰膝酸软,潮热盗汗,舌红少苔,脉细数,确诊为肝肾阴虚型前列腺炎。各处求医,多方治疗,效果均不佳,反复发作。随后经朋友介绍服用本发明中药制剂,2个疗程后,症状得到缓解,再持续服用4个疗程后治愈,之后未见复发。
虽然,上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。
Claims (5)
1.一种治疗前列腺炎的中药制剂,其特征在于,所述中药制剂由如下重量份数的原料制成:大金刀15-20份、牛抄藤10-15份、西瓜翠衣10-15份、铁树叶15-20份、半枝莲15-20份、首乌藤10-20份、泽兰6-12份、黄精10-15份、功劳子5-9份、薏苡根9-15份、桑葚10-15份、五加皮6-15份、艾实2-5份、郁金3-10份、白屈菜3-6份。
2.如权利要求1所述的治疗前列腺炎的中药制剂,其特征在于,所述中药制剂由如下重量份的原料制成:大金刀17-19份、牛抄藤12-14份、西瓜翠衣12-14份、铁树叶17-19份、半枝莲17-19份、首乌藤13-17份、泽兰8-10份、黄精12-14份、功劳子6-8份、薏苡根11-14份、桑葚12-14份、五加皮9-13份、艾实3-4份、郁金5-8份、白屈菜4-5份。
3.如权利要求2所述的治疗前列腺炎的中药制剂,其特征在于,所述中药制剂由如下重量份的原料制成:大金刀18份、牛抄藤13份、西瓜翠衣13份、铁树叶18份、半枝莲18份、首乌藤15份、泽兰9份、黄精13份、功劳子7份、薏苡根12份、桑葚13份、五加皮11份、艾实4份、郁金7份、白屈菜5份。
4.如权利要求1-3任一所述的治疗前列腺炎的中药制剂,其特征在于:所述中药制剂为颗粒剂、片剂或胶囊剂。
5.如权利要求4所述的治疗前列腺炎的中药制剂的制备方法,其特征在于所述制备方法包括以下步骤:
1)按照上述重量份称取所述原料;
2)将步骤1)所取的原料洗净晾干后,切断至长度小于1cm;而后加入原料总质量8-10倍且体积浓度为60-80%的乙醇溶液浸泡1-3h,随后回流提取2-3次,每次1-2h,合并每次提取所得滤液,减压回收乙醇,再进行浓缩、干燥、粉碎,得醇提取物干粉;醇提取所剩余的药渣保留,备用;
3)向步骤2)醇提取所剩余的药渣中加入原料总重量6-8倍的水,加热回流提取2次,每次2-3小时,合并两次提取液,进而进行浓缩、干燥、粉碎,得水提取物干粉;
4)将步骤2)所得醇提取物干粉和步骤3)所得水提取物干粉混合均匀,加入药学上可以接收的辅料,制成颗粒剂、片剂或胶囊剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610052865.1A CN105535861B (zh) | 2016-01-27 | 2016-01-27 | 一种治疗前列腺炎的中药制剂及其制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610052865.1A CN105535861B (zh) | 2016-01-27 | 2016-01-27 | 一种治疗前列腺炎的中药制剂及其制作方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105535861A CN105535861A (zh) | 2016-05-04 |
CN105535861B true CN105535861B (zh) | 2017-02-22 |
Family
ID=55815743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610052865.1A Expired - Fee Related CN105535861B (zh) | 2016-01-27 | 2016-01-27 | 一种治疗前列腺炎的中药制剂及其制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105535861B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101972402A (zh) * | 2010-10-10 | 2011-02-16 | 毛成艺 | 一种治疗前列腺炎的中药 |
CN104524294A (zh) * | 2014-12-30 | 2015-04-22 | 青岛市中心医院 | 一种治疗前列腺炎的中药配方 |
-
2016
- 2016-01-27 CN CN201610052865.1A patent/CN105535861B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101972402A (zh) * | 2010-10-10 | 2011-02-16 | 毛成艺 | 一种治疗前列腺炎的中药 |
CN104524294A (zh) * | 2014-12-30 | 2015-04-22 | 青岛市中心医院 | 一种治疗前列腺炎的中药配方 |
Non-Patent Citations (1)
Title |
---|
孟澍江教授治疗前列腺炎经验;吴成;《陕西中医》;19931231;第14卷(第10期);454-455页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105535861A (zh) | 2016-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103099959A (zh) | 一种治疗溃疡性结肠炎的中药制剂及其制备方法 | |
CN104013825A (zh) | 一种治疗糖尿病的中药组合物 | |
CN106720815A (zh) | 一种调理前列腺疾病的石斛咖啡及其制备方法 | |
CN103690919A (zh) | 用于治疗仔猪缺铁性贫血的药物及其制备方法 | |
CN102058715B (zh) | 一种治疗慢性前列腺炎的中药制剂及其制备方法 | |
CN107496719A (zh) | 一种提高男性功能的药酒及其制备方法 | |
CN102366541B (zh) | 一种治疗消渴病的中药组合物 | |
CN103316245B (zh) | 一种治疗小儿遗尿的中药制剂及其制备方法 | |
CN104491831A (zh) | 一种治疗致密性骶髂骨关节炎的中药制剂及其制备方法 | |
CN102406798B (zh) | 用于治疗重症肌无力的中药组合物 | |
CN102000164A (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
CN101607011B (zh) | 一种治疗胆囊炎术后并发症的中药药物 | |
CN103520655A (zh) | 一种治疗寻常型银屑病的中药组合物及其制备方法 | |
CN101234184B (zh) | 一种内服治疗放射性直肠炎的中药组合物 | |
CN103330888B (zh) | 用于治疗外阴瘙痒的中药组合物及清洗液 | |
CN104940718A (zh) | 一种治疗慢性胆囊炎的药物组合物及其制备方法 | |
CN105169018A (zh) | 一种普外科治疗痔疮的中药组合物 | |
CN104043058A (zh) | 一种治疗肾虚型腰椎间盘突出的中药制剂及其制备方法 | |
CN105535861B (zh) | 一种治疗前列腺炎的中药制剂及其制作方法 | |
CN103735792B (zh) | 一种治疗月经不调的药物及其制备方法 | |
CN102805825B (zh) | 一种治疗皮肤瘙痒症的药物及其制备方法 | |
CN104940672A (zh) | 一种治疗胆囊结石的中药及制备方法 | |
CN105106696A (zh) | 一种治疗慢性前列腺炎的中药组合物 | |
CN108042744A (zh) | 一种用于治疗前列腺疾病的中药组合物及制备方法 | |
CN106668696A (zh) | 一种治疗原发性胆汁性肝硬化的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170222 |
|
CF01 | Termination of patent right due to non-payment of annual fee |